NEUROPEPTIDE & SIGNALING RESEARCH
Neuropeptide Research Library
Research records organized around sequence identity, receptor context, experimental timing, model selection and the limits of translating one endpoint into another.
Official compound records
Priority products appear first. Each link keeps the existing product page as the canonical commercial and compound record.
OFFICIAL PRODUCT RECORDAdamax Open the existing product URL for identity, strengths and documentation.OFFICIAL PRODUCT RECORDDelta Sleep-Inducing Peptide (DSIP) Open the existing product URL for identity, strengths and documentation.OFFICIAL PRODUCT RECORDSelank Open the existing product URL for identity, strengths and documentation.OFFICIAL PRODUCT RECORDSemax Open the existing product URL for identity, strengths and documentation.OFFICIAL PRODUCT RECORDVIP (Vasoactive Intestinal Peptide) Open the existing product URL for identity, strengths and documentation.
Related comparisons
Comparison pages retain their pairwise keyword intent and link back to both product records.
Research guides
Each guide answers a distinct evidence, terminology or analytical question within this subject.
BLOGDoes DSIP Always Increase Sleep? Why Species, Sequence, and EEG Endpoint Change the Answer Learn why DSIP sleep findings vary with peptide identity, species, baseline condition, route, observation window, and the exact EEG or sleep endpoint.BLOGReading Semax Animal Studies: Time Points, Controls, and Replication Read Semax animal studies through sampling times, control groups and independent replication. Understand what molecular findings can and cannot support.BLOGSemax Stability Studies: Why an Intact Peptide Signal Is Not the Same as a Fragment Profile Learn why Semax parent-peptide detection, degradation rate, and fragment identification require separate analytical questions and method details.BLOGSemax Transcriptome Studies: Reading Gene Expression Without Overreach Understand Semax RNA-seq evidence, comparison groups, gene-expression statistics and protein follow-up while preserving the limits of rat-model studies.LEARNVIP Receptor Studies: Why VPAC1, VPAC2, and PAC1 Cannot Be Treated as One Readout Learn why VIP receptor evidence must identify VPAC1, VPAC2, or PAC1, plus the expression system, ligand, binding method, and signaling endpoint.
Primary destinations
This topic supports the product records above and returns authority to the site's main research utilities.
Research-use boundary: This directory organizes product identity, analytical documentation and nonclinical research context. It does not provide medical advice, dosing guidance or an administration protocol. NextWave products are intended exclusively for lawful laboratory research and are not intended for human or veterinary use.